23andMe Holding Co (ME)
3.82
-0.43
(-10.12%)
USD |
NASDAQ |
Nov 14, 16:00
3.82
0.00 (0.00%)
After-Hours: 04:49
23andMe Free Cash Flow (Quarterly): -44.57M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -44.57M |
March 31, 2024 | -27.95M |
December 31, 2023 | -14.07M |
September 30, 2023 | -59.89M |
June 30, 2023 | -72.06M |
March 31, 2023 | -48.25M |
December 31, 2022 | 22.48M |
September 30, 2022 | -74.99M |
June 30, 2022 | -75.94M |
Date | Value |
---|---|
March 31, 2022 | -38.40M |
December 31, 2021 | -26.26M |
September 30, 2021 | -70.22M |
June 30, 2021 | -45.92M |
March 31, 2021 | -41.06M |
December 31, 2020 | 27.46M |
September 30, 2020 | -30.58M |
June 30, 2020 | -37.46M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-75.94M
Minimum
Jun 2022
27.46M
Maximum
Dec 2020
-38.69M
Average
-41.06M
Median
Mar 2021
Free Cash Flow (Quarterly) Benchmarks
RadNet Inc | 36.55M |
iSpecimen Inc | -1.259M |
Delcath Systems Inc | -3.856M |
CytoSorbents Corp | -2.760M |
Progyny Inc | 55.83M |